L. Carrara

发表

High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.

P. Schwartz, T. Rutherford, P. Todeschini, 2011, Gynecologic oncology.

Expression of Tissue factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix: Implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor

D. Silasi, P. Schwartz, T. Rutherford, 2011, BMC Cancer.

Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab

E. Ratner, D. Silasi, T. Rutherford, 2011, British Journal of Cancer.

Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor

D. Silasi, P. Schwartz, T. Rutherford, 2011, Clinical & Experimental Metastasis.

HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor.

P. Schwartz, T. Rutherford, E. Cocco, 2013, Gynecologic oncology.

Expression of &agr;V-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti-&agr;V-Integrin Antibody

P. Schwartz, T. Rutherford, P. Todeschini, 2011, International Journal of Gynecologic Cancer.

Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expression.

E. Sartori, P. Schwartz, T. Rutherford, 2012, Gynecologic oncology.

Cancer in pregnancy: maternal and fetal implications on decision-making.

E. Sartori, T. Maggino, S. Pecorelli, 2011, European journal of gynaecological oncology.

HER2/neu as a Potential Target for Immunotherapy in Gynecologic Carcinosarcomas

R. Angioli, P. Schwartz, T. Rutherford, 2012, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma

T. Boggon, Murim Choi, Shrikant Mane, 2013, Proceedings of the National Academy of Sciences.

Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients.

E. Sartori, S. Pecorelli, A. Gambino, 2007, Gynecologic oncology.

Could Different Follow-Up Modalities Play a Role in the Diagnosis of Asymptomatic Endometrial Cancer Relapses?: An Italian Multicentric Retrospective Analysis

A. Gadducci, E. Sartori, F. Landoni, 2012, International Journal of Gynecologic Cancer.

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody

Paola Todeschini, Masoud Azodi, Marta Betti, 2011, Journal of experimental & clinical cancer research : CR.

Cancer in pregnancy: maternal and fetal implications on decision-making.

E. Sartori, T. Maggino, S. Pecorelli, 2011, European journal of gynaecological oncology.

Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcoma cell lines is linked to tubulin-beta-III expression.

E. Sartori, P. Schwartz, T. Rutherford, 2012, Gynecologic oncology.